Neurotransmitters Lec 7 Flashcards
Iontoropic NT receptors
Ligand-gated ion channels
4-5 subunits that each contain 3 or 4 transmembrane domains
Metabotropic NT receptors
G-protein-couple receptors
Monomeric proteins containing 7 transmembrane domains
Acetylcholine
PNS-NMJ
CNS-interneurons in brainstem/forebrain- involved in AD
ACh precursor
Acetyl CoA and Choline
ACh removal
Acetylcholinesterase
ACh organophosphates- insecticides and sarin
inhibit Acetylcholinesterase
ACh receptors
Ionotropic/nicotinic- excitatory
Metabotropic/muscarinic- brain and peripheral ganglia
- mediate responses of autonomic effector organs
ACh useful therapeutics
Atropine- antagonists- pupil dilation
Scopolamine- motion sickness
Myasthenia Gravis
Autoimmune Dz- against nAchR
increased turnover of receptors
muscle fatigue
Glutamate
Excitatory in brain
Excitotoxcity
High EC concentrations toxic to neurons
Glu precursor
Glutamine
Glu removal
Reuptake into terminal and glia
Glu receptors
Ionotropic- NMDA, AMPA, Kainite
Metabotropic- increase or decrease excitability of postsynaptic cell
GABA
Major inhibitory transmitter in CNS
GABA precursor
Glutamate
GABA removal
Reuptake into terminal and glia
Decreased GABA
can cause epilepsy
GABA receptors
Ionotropic- GABAa and GABAc
- open inhibitory Cl channels
- Benzodazepines and barbiturates
Metabotropic- GABAb
- in Brain
- produces inhibitory postsynaptic response
Glycine
Spinal cord
inhibitory
Gly precursor
Serine
Gly removal
Reuptake into terminal and glia
Gly Excess
Neonatal dz characterized by lethargy and MR
Gly Receptors
Ionotropic only- open inhibitory Cl channels
Strychnine
Blocks Gly receptors
causes overactivity leading to seizures
Dopamine
Catecholamine
found mostly in corpus striatum
Dopamine fxn
Coordination of body movement motivation reward reinforcement emotional behavior
Dopamine precursor
Tyrosine
Dopamine packaging
Vesicular monoamine transporter (VMAT)
Synthesis
Tyrosine-DOPA-Dopamine
Dopamine receptor
Metabotropic
Dopamine removal
Re-uptake into terminal
Parkinson Dz
Treated with L-DOPA to increase dopamine levels in striatum
Additive drugs
raise dopamine levels by interfering with reuptake
Amphetamine
inhibits both dopamine and NE transporters causing net increase in release of transmitters
NE
Catecholamine
CNS- wakefulness, attention, feeding behavior
PNS- Sympathetic motor system
NE precursor
Tyrosine
NE packaging
Vesicular monoamine transporter (VMAT)
NE synthesis
Tyrosine-DOPA-Dopamine-NE-Epi
NE receptor
Metabotropic
NE removal
reuptake into terminal
NE uses
Amphetamine
anti-anxiety drugs
anti-depressants
Serotonin
Regulation of sleep, eating, wakefulness and arousal
Serotonin precursor
Tryptophan
Serotonin Synthesis
Tryptophan- 5hydroxytryptophan- serotonin
Serotonin receptors
Metabotropic- impaired in many psychiatric disorders
Ionotropic- minor one
Serotonin removal
Specific serotonin transporter (SERT)- into terminal
Serotonin uses
Anti-anxiety
anti-depressants
Neuropeptides
Emotions, perception of pain, responses to stress
Neuropeptide categories
Brain-gut
Opiod
Pituitary
hypothalamic-releasing
Neuropeptide precursor
Amino acids in ER
Neuropeptide receptors
metabotropic
Neuropeptide removal
peptidases
Anti-psychotic drugs
Block dopamine receptors
Anti-anxiety drugs
MAO inhibitors block breakdown of biogenic amines
inhibitors of serotonin reuptake
Anti-depressants
MAO inhibitors block breakdown of biogenic amines
Tricyclic block reuptake of NE and 5HT
Serotonin reuptake inhibitors(Prozac) act on serotonin transporters